Novartis AG (NVS)
132.36
+1.17
(+0.89%)
USD |
NYSE |
Dec 11, 16:00
131.00
-1.36
(-1.03%)
After-Hours: 20:00
Novartis Cash from Investing (Quarterly): -858.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Avidity Biosciences, Inc. | -587.93M |
| Monte Rosa Therapeutics, Inc. | 38.14M |
| Tourmaline Bio, Inc. | 16.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 6.574B |
| Cash from Financing (Quarterly) | -2.754B |
| Free Cash Flow | 17.15B |
| Free Cash Flow Per Share (Quarterly) | 2.961 |
| Free Cash Flow to Equity (Quarterly) | 6.359B |
| Free Cash Flow to Firm (Quarterly) | 6.007B |
| Free Cash Flow Yield | 6.57% |